Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer

Genomic studies performed through liquid biopsies widely elucidated the evolutionary trajectory of RAS mutant clones under the selective pressure of EGFR inhibitors in patients with wild type RAS primary colorectal tumors. Similarly, the disappearance of RAS mutant clones in plasma has been more rec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Raimondi, Cristina, Nicolazzo, Chiara, Belardinilli, Francesca, Loreni, Flavia, Gradilone, Angela, Mahdavian, Yasaman, Gelibter, Alain, Giannini, Giuseppe, Cortesi, Enrico, Gazzaniga, Paola
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Communication
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6357143/
https://ncbi.nlm.nih.gov/pubmed/30621206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11010042
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak